Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of the formation and development of teeth, the hard, bony appendages which are borne on the jaws, or on other bones in the walls of the mouth or pharynx of most vertebrates. [GOC:jl, GOC:mtg_sensu, PMID:15355794]
Odontogenesis, the development of teeth, is a complex and highly regulated process involving a series of precisely orchestrated events. Dentinogenesis, the formation of dentin, a mineralized tissue that forms the bulk of the tooth, is a crucial part of this process. Regulation of dentinogenesis involves a complex interplay of signaling molecules, transcription factors, and extracellular matrix components.
**Initiation and Induction:**
- The process begins with the formation of the dental lamina, an epithelial structure arising from the oral epithelium.
- Signals from the underlying mesenchyme, the dental papilla, induce the dental lamina to invaginate and form the enamel organ.
- Within the enamel organ, ameloblasts differentiate, responsible for enamel formation, while the dental papilla cells differentiate into odontoblasts, the cells responsible for dentin formation.
**Odontoblast Differentiation and Dentinogenesis:**
- Odontoblast differentiation is initiated by a cascade of signaling events involving factors like BMPs (Bone Morphogenetic Proteins), FGFs (Fibroblast Growth Factors), and Wnt signaling pathways.
- Once differentiated, odontoblasts synthesize and secrete the organic matrix of dentin, known as predentin, which is composed of collagen type I, dentin sialophosphoprotein (DSPP), dentin matrix protein 1 (DMP1), and other proteins.
- As predentin is deposited, it undergoes mineralization, with the deposition of calcium and phosphate ions forming hydroxyapatite crystals.
- Mineralization is regulated by a variety of factors, including alkaline phosphatase, dentin sialoprotein (DSP), and matrix metalloproteinases (MMPs).
**Regulation of Dentinogenesis:**
- **Signaling Pathways:**
- BMPs, FGFs, and Wnt signaling pathways play crucial roles in initiating and regulating odontoblast differentiation and dentinogenesis.
- TGF-beta (Transforming Growth Factor-beta) signaling is also involved in regulating dentinogenesis.
- **Transcription Factors:**
- Transcription factors like Runx2, Msx1, and Osterix are essential for odontoblast differentiation and dentin formation.
- Other transcription factors, like Sox2, Pax9, and Pitx2, also contribute to the regulation of odontogenesis.
- **Extracellular Matrix Components:**
- Collagen type I is the major component of the dentin matrix and provides structural support.
- Non-collagenous proteins, like DSPP, DMP1, and DSP, are involved in regulating mineralization, cell adhesion, and matrix organization.
**Maintenance of Odontoblast Function:**
- Once dentinogenesis is initiated, odontoblasts continue to deposit dentin throughout life, forming secondary dentin.
- The regulation of this process involves various signaling pathways and feedback mechanisms to maintain odontoblast function and ensure the continued formation of dentin.
**Overall, the regulation of dentinogenesis is a complex and dynamic process involving multiple cellular and molecular events. This intricate regulation ensures the formation of a strong and durable dentin matrix, essential for the function and integrity of the tooth.**'
"
Protein | Definition | Taxonomy |
---|---|---|
Bone morphogenetic protein 4 | A bone morphogenetic protein 4 that is encoded in the genome of human. [PRO:CNA, UniProtKB:P12644] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
dorsomorphin | dorsomorphin : A pyrazolopyrimidine that is pyrazolo[1,5-a]pyrimidine which is substituted at positions 3 and 6 by pyridin-4-yl and p-[2-(piperidin-1-yl)ethoxy]phenyl groups, respectively. It is a potent, selective, reversible, and ATP-competitive inhibitor of AMPK (AMP-activated protein kinase, EC 2.7.11.31) and a selective inhibitor of bone morphogenetic protein (BMP) signaling. dorsomorphin: an AMPK inhibitor | aromatic ether; piperidines; pyrazolopyrimidine; pyridines | bone morphogenetic protein receptor antagonist; EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor |
ldn 193189 | LDN 193189: inhibits bone morphogenetic protein signaling | pyrimidines | |
ml347 | ML347: an ALK2 inhibitor; structure in first source |